SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflixs upcoming Q3 earnings report is the main focus, with traders watching guidance, subscriber engagement and advertising growth after a steep share-price decline and recent layoffs and content-leadership changes. Views are split between hopes for a rebound if results or outlook exceed subdued expectations and bets on further losses if growth concerns persist.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Modernas rally is drawing attention as traders position around the full Phase 3 melanoma cancer-vaccine data presentation at ESMO, following previously reported positive topline results. Bulls see the readout as validation of the oncology pipeline, while skeptics warn that expectations and valuation are elevated and debate whether the event could prompt profit-taking.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

SRPTs sharp rebound is drawing attention, with traders attributing the move to possible short covering and technical buying rather than a confirmed new company announcement. The broader debate centers on upcoming DM1 and FSHD siRNA data: Novartis/Aviditys DM1 trial failure raised concerns about whether target knockdown can translate into patient benefit, while some traders argue Sareptas distinct delivery approach and the loss of a competitor could be favorable.

Sea Ltd. is an internet and mobile platform company, which engages in the provision of online gaming services. It operates through the following segments: Digital Entertainment, E-Commerce, and Digital Financial Services. The Digital Entertainment segment offers and develops mobile and PC online games. The E-Commerce segment manages a third-party marketplace through the Shopee mobile app and websites that connect buyers and sellers. The Digital Financial Services segment includes a variety of payment services and loans to individuals and businesses through SeaMoney. Sea was founded by Xiao Dong Li, Gang Ye, and Jing Ye Chen on May 8, 2009 and is headquartered in Singapore.

Sea Ltd - ADR

Seas sharp selloff and fresh low are being linked by traders to plans for a potential Monee listing and the launch of Sea Cloud, alongside concerns about spending and competition in e-commerce. Some see a Monee separation as value-unlocking, while others view the plans and uncertainty around them as a reason to sell; claims of further undisclosed bad news remain speculation.

GE Aerospace is an American aircraft company, which engages in the provision of jet and turboprop engines, as well as integrated systems for commercial, military, business, and general aviation aircraft. The firm's portfolio of brands includes Avio Aero, Unison, GE Additive, and Dowty Propellers. It operates through the following segments: Commercial Engines and Services, Defense and Propulsion Technologies, and Corporate and Other. The Commercial Engines and Services segment is involved in the design, development, manufacturing, and servicing of jet engines for commercial airframes, as well as business aviation and aeroderivative applications. The Defense and Propulsion Technologies segment offers defense engines and critical aircraft systems. The Corporate and Other segment relates to corporate functions and operations costs. The company was founded by Thomas Alva Edison in 1878 and is headquartered in Evendale, OH.

GE Aerospace

GE Aerospaces earnings beat and raised outlook drew attention as shares sold off despite strong demand, with traders frustrated by the reaction. The debate centers on whether higher costs, weaker cash generation and an insurance loss outweigh the stronger orders and guidance.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

Attention centers on TG Therapeutics MSToronto presentations, especially initial Phase 1 azer-cel data in progressive MS and additional BRIUMVI results, with commercial growth and a future subcutaneous formulation also part of the bullish case. Traders are anticipating a catalyst-driven move, though some caution that the azer-cel results remain uncertain and complain that the shares have struggled to break out of a trading range.

General Motors Co. engages in the designing, manufacturing, and selling of trucks, crossovers, cars, and automobile parts, and in providing software-enabled services and subscriptions. It operates through the following segments: GMNA, GMI, Cruise, and GM Financial. The company was founded by William C. Durant on September 16, 1908 and is headquartered in Detroit, MI.

General Motors Company

GM is selling off despite a third-quarter earnings beat and a new buyback authorization, as traders focus on narrowed full-year profit guidance with an unchanged midpoint and weaker vehicle sales. Some view the drop as overdone given the stronger cash-flow outlook and buyback, while others see the outlook as too cautious to offset the earnings-day disappointment.

Myriad Genetics, Inc. is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. It develops and commercializes molecular tests that help patients and providers uncover genetic insights. The company was founded by Walter A. Gilbert, Mark H. Skolnick, and Peter D. Meldrum in May 1991 and is headquartered in Salt Lake City, UT.

Myriad Genetics, Inc.

Myriad Genetics agreement to sell its prenatal testing business to Labcorp is driving a sharp rally, with traders viewing the cash proceeds as a balance-sheet and strategic boost. Others question the deal because the divested unit contributes revenue, raising concerns about debt and the outlook for the remaining business; some traders are also taking profits after the surge.

The Boeing Co. is an aerospace company, which engages in the manufacture of commercial jetliners and defense, space, and security systems. It operates through the following segments: Commercial Airplanes (BCA), Defense, Space and Security (BDS), and Global Services (BGS). The Commercial Airplanes segment includes the development, production, and market of commercial jet aircraft and provides fleet support services, principally to the commercial airline industry worldwide. The Defense, Space and Security segment refers to the research, development, production and modification of manned and unmanned military aircraft and weapons systems for global strike, including fighter and combat rotorcraft aircraft and missile systems, global mobility, including tanker, rotorcraft and tilt-rotor aircraft, and airborne surveillance and reconnaissance, including command and control, battle management and airborne anti-submarine aircraft. The Global Services segment provides services to commercial and defense customers. The company was founded by William Edward Boeing on July 15, 1916, and is headquartered in Arlington, VA.

Boeing Co.

Boeing Co

Traders are focused on an expected FAA certification announcement for Boeings 737 MAX 10, a long-delayed milestone they see as potentially easing a key overhang. Reactions are divided: some expect the approval to improve sentiment and support future deliveries, while skeptics say it may be priced in and that production execution, delivery pace and cash generation matter more.

Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA.

Rapport Therapeutics Inc.

Rapport Therapeutics Inc

RAP-219s Phase 2 trial in bipolar mania met its primary and secondary endpoints, prompting bullish trading and analyst optimism, including an upgrade. The community is divided over the modest placebo-adjusted benefit and concerns about agitation and discontinuations; the initial surge faded as traders debated whether the data justify further upside.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Dave & Buster's (PLAY) Up 7.7% Since Last Earnings Report: Can It Continue?

Dave & Buster's (PLAY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Bear of the Day: Dave & Buster's (PLAY)

Earnings decline continues as new QSR, health-focused, and entertainment options multiply in a vibrant economy

Tuesday Sector Laggards: Restaurants & Eateries, Credit Services & Lending Stocks

In trading on Tuesday, restaurants & eateries shares were relative laggards, down on the day by about 2.9%. Helping drag down the group were shares of Dave & Busters Entertainment, off about 19.3% and shares of Wingstop down about 10.5% on the day.

Also lagging the mar...

Futures Drop As Yields, Oil Prices Keep Rising

Futures Drop As Yields, Oil Prices Keep Rising

 Futures are lower - but well off session lows thanks to some well-time oil sell orders just before US traders walked in to work - as bond yields continue to make new highs, with both Nasdaq and Russell lagging the S&P which feels like...

Dave & Buster's Shares Are Falling Tuesday: What's Happening?

Dave & Buster's Entertainment shares are trading lower Tuesday after the company reported worse-than-expected Q2 results.read more...

PLAY Stock Sinks Premarket: Dave & Buster’s Q2 Miss Sparks A Wave Of Price Target Cuts 

Equity

Dave & Buster’s missed Q2 revenue and adjusted EPS expectations, sending shares lower and prompting multiple analysts to cut price targets while maintaining their ratings.


Dave & Buster's Entertainment, Forgent Power Solutions And 3 Stocks To Watch Heading Into Tuesday

Stocks in focus: Forgent reports earnings; Dave & Buster's and Children's Place missed estimates, while Vera Bradley and Trip.com await results.read more...

Dow, S&P 500, Nasdaq Futures Mixed Ahead Of Fed Rate Decision As AI Uncertainty Mounts: IOVA, PLAY, ELMT, RBLX Stocks In Focus

The Federal Open Market Committee (FOMC) meeting is scheduled for Sept. 15–16. 

PLAY Stock Tanks Overnight After Surprise Loss, But Retail Stays Bullish As CEO Sees Turnaround Signs 

Dave & Buster’s missed second-quarter revenue estimates as well. 

Compared to Estimates, Dave & Buster's (PLAY) Q2 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for Dave & Buster's (PLAY) give a sense of how the business performed in the quarter ended July 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Dave & Buster's Entertainment, Inc. engages in the ownership and operation of entertainment and dining venues under the name Dave & Buster's. It offers a full menu of entrées and appetizers, a selection of alcoholic and non-alcoholic beverages, and an assortment of entertainment attractions centered around playing games and watching live sports and other televised events. The company was founded by David O. Corriveau and James W. Corley in 1982 and is headquartered in Coppell, TX.

Dave & Buster`s Entertainment Inc

Bearish Sentiment

<ul class="summary-bullets"><li>Texas Capital lowered its target to $16 from $23 while keeping a Buy rating; Gordon Haskett and Freedom Capital cut their targets to $9 from $13, both maintaining Hold ratings,&nbsp;</li><li>CEO Darin Harper is pushing the “Back-to-Basics” strategy, with management highlighting improving sales trends, new games and attractions, cost savings and two additional remodels planned for the rest of FY2026.</li><li>Entertainment-related sales declined to&nbsp; $332.6 million, while adjusted EBITDA fell to $98.9 million from $129.8 million a year ago.</li></ul><p>Dave &amp; Buster’s (PLAY) is facing a wave of price-target cuts after its second-quarter results fell short of expectations, with analysts lowering their targets while maintaining their existing ratings on the stock.</p><p>The moves came after Dave &amp; Buster’s reported a weaker-than-expected fiscal second quarter, sending shares sharply lower in premarket trading.</p><p>According to reports from The Fly, Texas Capital cut its price target to $16 from $23 while maintaining a ‘Buy’ rating. Gordon Haskett lowered its target to $9 from $13 and kept a ‘Hold' rating, while Freedom Capital also reduced its target to $9 from $13 and maintained a ‘Hold’ rating, UBS also cut its price target to $9 from $12 .</p><p><a href="https://stocktwits.com/symbol/PLAY">PLAY&nbsp;</a>&nbsp;shares fell nearly 12% in premarket trading Tuesday at the time of writing.</p><h2 class="st-heading-2">Q2 Results Fall Short</h2><p>The entertainment and dining company reported Q2 revenue of $544.1 million, down 2.4% year over year, missing the $556.83 million consensus estimate, according to Fiscal AI. On an adjusted basis, Dave &amp; Buster’s posted a loss of $0.27 per share, compared with the $0.19 profit analysts had anticipated.</p><p>The earnings miss was broad, with the company reporting an adjusted net loss of $9.5 million, or $0.27 per share, versus adjusted net income of $14.2 million, or $0.40 per share, in the prior-year quarter.</p><h2 class="st-heading-2">Entertainment Sales Remain A Key Pressure Point</h2><p>The biggest weakness came from Dave &amp; Buster’s core entertainment business. Entertainment-related sales fell nearly 9% to $332.6 million.</p><p>Comparable-store sales declined 2.9%, although that was better than the roughly 3.4% decline analysts had expected. The company also reported adjusted earnings before interest, taxes, depreciation, and amortization(EBITDA) of $98.9 million, down from $129.8 million a year earlier, with the adjusted EBITDA margin falling to 18.2% from 23.3%.</p><p>The results highlight the challenge facing CEO Darin Harper, who took over last month. Harper acknowledged that the company has fallen behind on innovation and keeping its entertainment offerings relevant to customers.</p><h2 class="st-heading-2">Wall Street Cuts Price Targets</h2><p>The disappointing quarter prompted several analysts to lower their price targets, although the firms maintained their existing ratings on PLAY.</p><p>According to reports from The Fly, Texas Capital, Gordon Haskett and Freedom Capital reduced its targets. The cuts are notable because none of the three firms changed their underlying ratings. Instead, analysts appear to be lowering their valuation expectations while remaining divided on the longer-term outlook.</p><p>UBS also lowered its price target to $9 from $12 while maintaining a ‘Neutral’ rating, Analyst Dennis Geiger said sales trends are showing early signs of improvement, but greater-than-expected margin and earnings pressure, elevated macro risks and limited visibility suggest the turnaround remains in its early stages.</p><div><figure class="table"><table class="ck-table-resized"><colgroup><col><col><col></colgroup><tbody><tr><td>Analyst</td><td>Old PT</td><td>New PT</td></tr><tr><td>UBS</td><td>$12</td><td>$9</td></tr><tr><td>Texas Capital&nbsp;</td><td>$23</td><td>$16</td></tr><tr><td>Gordon Haskett</td><td>$13</td><td>$9</td></tr><tr><td>Freedom Capital</td><td>$13</td><td>$9</td></tr></tbody></table></figure></div><p>According to data from MarketWatch, five of the 12 analysts covering Dave &amp; Buster’s maintain a ‘Buy' rating on the stock, while seven have a ‘Hold’ rating.&nbsp;</p><h2 class="st-heading-2">Management Bets On A Turnaround</h2><p>CEO Darin Harper, who recently took over the top job, said the company's “Back-to-Basics” strategy is gaining momentum.</p><p>Management said food-and-beverage sales continued to grow, while special-events sales also remained a source of strength. Harper acknowledged that the company has work to do on innovation and keeping its entertainment offerings relevant, noting that 10 new games and attractions introduced this year are performing well.&nbsp;</p><p>Harper said the company is also focused on margin management, cost savings and free cash flow as part of the turnaround effort. Management has identified $15 million in cost savings over the next 12 months, with additional opportunities under review.</p><p>The company plans to complete two additional domestic remodels during the remainder of fiscal 2026, bringing the full-year remodel count to eight.</p><h2 class="st-heading-2">Retail Take on PLAY stock</h2><p>On Stocktwits, retail sentiment around PLAY jumped from ‘bullish’ to ‘extremely bullish’ over the past 24 hours, while message volume increased from ‘high’ to ‘extremely high’ levels.</p><p>PLAY stock has dropped nearly 48% year-to-date.</p><p><strong>Read more:&nbsp;</strong><a href="https://stocktwits.com/news-articles/markets/cryptocurrency/arbitrum-is-hugely-undervalued-70x-arb-upside-after-robinhood-chain-launch/cZtn4muRBTU"><strong>Arbitrum Is ‘Hugely Undervalued,’ Standard Chartered Says – Forecasts 70X ARB Upside After Robinhood Chain Launch</strong></a></p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p>

In this photo illustration, a smartphone displays the logo of Dave & Buster's Entertainment, Inc. (NASDAQ: PLAY), an American entertainment and restaurant company operating arcade, dining and sports-viewing venues across North America, in front of a screen showing the company's latest stock market chart on June 15, 2026 in Shenzhen, Guangdong Province, China. (Photo illustration by Cheng Xin/Getty Images)

Dave & Buster’s missed Q2 revenue and adjusted EPS expectations, sending shares lower and prompting multiple analysts to cut price targets while maintaining their ratings.

PLAY Stock Sinks Premarket: Dave & Buster’s Q2 Miss Sparks A Wave Of Price Target Cuts

Dave & Buster's Entertainment

Double beat (rev + EPS)

Revenue beat, EPS miss

EPS beat, revenue miss

Double miss

SpaceX ($SPCX) reports earnings after the close today. What do you expect?

Stocktwits

SpaceX

) reports earnings after the close today. What do you expect?

Current Price	$7.87
Prev Close	$7.71
Open	$8.00
Dividend Yield	0.00%
50-Day Moving Average	$8.17
Beta	1.35
Avg. Volume	3.35M
PE Ratio	-3.01

52-Week High	$22.10
52-Week Low	$6.26
Market Capitalization	$268.54M
EPS (Annual)	-$1.40
Price to Book	3.06
Revenue Per Employee	$89,063.96

Feed

News

Sentiment

Earnings

Fundamentals

Info

PLAY Fundamentals